Literature DB >> 27172359

Predisposing Factors in Acute-on-Chronic Liver Failure.

Jonel Trebicka1.   

Abstract

Acute-on-chronic liver failure (ACLF) is a syndrome with high short-term mortality in patients with chronic liver disease. The definition of ACLF has been addressed recently in many publications, and despite regional differences the number and severity of organ failures are decisive for the presence and severity of ACLF. However, the predisposition of patients to develop ACLF has not been addressed in prospective studies. Several predisposing factors for ACLF have been mentioned, but still clear-cut analysis and the sequential processes have not been explored. One reason is that different factors might predispose in one setting and might be the precipitating event in another, thus rendering the generalization of predisposing factors difficult. However, genetic factors, lifestyle, past medical history, aging, latent chronic infections, and the severity of the liver disease and portal hypertension might predispose for the development of ACLF after proper injury and response. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27172359     DOI: 10.1055/s-0036-1583195

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  10 in total

Review 1.  Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.

Authors:  Jonel Trebicka; Peer Bork; Aleksander Krag; Manimozhiyan Arumugam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-30       Impact factor: 46.802

2.  FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts.

Authors:  Simone Anna Keimburg; Jens Theysohn; Matthias Buechter; Jassin Rashidi-Alavijeh; Katharina Willuweit; Hannah Schneider; Axel Wetter; Benjamin Maasoumy; Christian Lange; Heiner Wedemeyer; Antoaneta Angelova Markova
Journal:  Biomedicines       Date:  2022-04-28

Review 3.  Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure.

Authors:  Jonel Trebicka; Thomas Reiberger; Wim Laleman
Journal:  Visc Med       Date:  2018-07-13

4.  Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis.

Authors:  Michael Praktiknjo; Jennifer Lehmann; Mette J Nielsen; Robert Schierwagen; Frank E Uschner; Carsten Meyer; Daniel Thomas; Christian P Strassburg; Flemming Bendtsen; Søren Møller; Aleksander Krag; Morten A Karsdal; Diana J Leeming; Jonel Trebicka
Journal:  Hepatol Commun       Date:  2018-01-18

Review 5.  Managing portal hypertension in patients with liver cirrhosis.

Authors:  Tilman Sauerbruch; Robert Schierwagen; Jonel Trebicka
Journal:  F1000Res       Date:  2018-05-02

6.  Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis.

Authors:  Jennifer Lehmann; Michael Praktiknjo; Mette Juul Nielsen; Robert Schierwagen; Carsten Meyer; Daniel Thomas; Francesco Violi; Christian P Strassburg; Flemming Bendtsen; Søren Møller; Aleksander Krag; Morten Asser Karsdal; Diana Julie Leeming; Jonel Trebicka
Journal:  Liver Int       Date:  2019-03-07       Impact factor: 5.828

Review 7.  [Treatment strategies for acute-on-chronic liver failure].

Authors:  A-R Kabbani; T L Tergast; M P Manns; B Maasoumy
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-28       Impact factor: 0.840

8.  Therapeutic Effects and Associated Mechanisms by which "Fuyang Jiedu Huayu" Granules Treat Chronic Liver Failure in the Rat.

Authors:  Qianling Ye; Hainan Jiang; Yanmei Lan; Minggang Wang; Dewen Mao
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-17       Impact factor: 2.629

9.  Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver Failure.

Authors:  Johannes Chang; Avend Bamarni; Nina Böhling; Xin Zhou; Leah-Marie Klein; Jonathan Meinke; Georg Daniel Duerr; Philipp Lingohr; Sven Wehner; Maximilian J Brol; Jürgen K Rockstroh; Jörg C Kalff; Steffen Manekeller; Carsten Meyer; Ulrich Spengler; Christian Jansen; Vicente Arroyo; Christian P Strassburg; Jonel Trebicka; Michael Praktiknjo
Journal:  Hepatol Commun       Date:  2021-03-26

10.  The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver Disease.

Authors:  Robert Schierwagen; Frank E Uschner; Cristina Ortiz; Sandra Torres; Max J Brol; Olaf Tyc; Wenyi Gu; Christian Grimm; Stefan Zeuzem; Andreas Plamper; Philipp Pfeifer; Sebastian Zimmer; Christoph Welsch; Liliana Schaefer; Karl P Rheinwalt; Joan Clària; Vicente Arroyo; Jonel Trebicka; Sabine Klein
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.